Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures

Pharmacological Reports

Volumn 60, Issue 4, 2008, Pages 574-577

  Luchowska, Elzbieta ^a   Kloc, Renata ^a   Wnuk, Sebastian ^a   Olajossy, Bartosz ^a   Wielosz, Marian ^a   Urbańska, Ewa M ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Glial culture; In vitro; Kynurenic acid; adrenergic agonist

Indexed keywords

CLENBUTEROL; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE; TIMOLOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; GLIA CELL; IN VITRO STUDY; MALE; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

EID: 52049102920     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anderson GP: Interactions between corticosteroids and β-adrenergic agonists in asthma disease induction, progression, and exacerbation. Am J Respir Crit Care Med, 2000, 161, S188-196.
2. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F: Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci, 2001, 13, 2141-2147.
3. Chmiel-Perzyńska I, Perzyński A, Wielosz M, Urbańska EM: Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and D,L-homocysteine on the brain production of kynurenic acid. Pharmacol Rep, 2007, 59, 268-273.
4. Culmsee C, Stumm RK, Schafer MK, Weihe E, Krieglstein J: Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol, 1999, 379, 33-45.
5. Giulian D, Baker TJ: Charactarization of ameboid microglia isolated from developing mammalian brain. J Neurosci, 1986, 6, 2163-2178.
6. Hertz L, Chen Y, Gibbs ME, Zang P, Peng L: Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders? Curr Drug Targets CNS Neurol Disord, 2004, 3, 239-267.
7. Junker V, Becker A, Hühne R, Zembatov M, Ravati A, Culmsee C, Krieglstein J: Stimulation of β-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol, 2002, 446, 25-36.
8. Kocki T, Luchowski P, Luchowska E, Wielosz M, Turski WA, Urbańska EM: L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Neurosci Lett, 2003, 346, 97-100.
9. Kocki T, Wielosz M, Turski WA, Urbańska EM: Enhancement of brain kynurenic acid production by anticonvulsants-novel mechanism of antiepileptic activity? Eur J Pharmacol, 2006, 41, 147-151.
10. Kuc D, Rahnama M, Tomaszewski T, Rzeski W, Wejksza K, Urbanik-Sypniewska T, Parada-Turska J et al.: Kynurenic acid in human saliva - does it influence oral microflora? Pharmacol Rep, 2006, 58, 393-398.
11. 3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther, 2003, 305, 653-659.
12. Luccini E, Musante V, Neri E, Raiteri M, Pittaluga A: N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. J Neurosci Res, 2007, 85, 3657-3665.
13. Luchowska E, Luchowski P, Paczek F, Ziembowicz A, Kocki T, Turski WA, Wielosz M et al.: Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. J Neurosci Res, 2005, 79, 375-382.
14. Marien MR, Colpaert FC, Rosenquist AC: Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev, 2004, 45, 38-78.
15. Németh H, Toldi J, Vecsei L: Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res, 2005, 2, 249-260.
16. Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J: Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res, 1996, 717, 44-54.
17. Stazka J. Luchowski P, Wielosz M, Kleinrok Z, Urbańska EM: Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine. Eur J Pharmacol, 2002, 448, 133-137.
18. Urbańska EM, Luchowski P, Luchowska E, Pniewski J, Woźniak R, Chodakowska-Zebrowska M, Łazarewicz J: Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine a study in stroke patients. Pharmacol Rep, 2006, 58, 501-511.
19. Vincent VAM, Van Dam A-M, Persoons JHA, Schotanus K, Steinbusch HWN, Schoffelmeer ANM, Berkenbosch F: Gradual inhibition of inducible nitric oxide synthase but not interleukin-1β production in rat microglial cells of endotoxin-treated mixed glial cell cultures. Glia, 1996, 17, 94-402.